4 stress in a cell or tissue. This is problematic given the low concentrations of both DHA and the AFR in cells, as well as their instability. To study intracellular ascorbate recycling, it is crucial to use an oxidant that has little effect on cell metabolism beyond that related to ascorbate. Therefore, to selectively oxidize intracellular ascorbate we used the oxidant ferricyanide, which does not cross erythrocyte cell membrane (25) and does not affect intracellular GSH concentrations (26) . Ferricyanide accepts electrons from a trans-plasma membrane oxidoreductase that uses ascorbate as an intracellular donor (27) (28) (29) . Although ferricyanide generates both the AFR and DHA within erythrocytes (30, 31) , it is uncertain whether the DHA generated results from AFR oxidation or from AFR dismutation. In the experiments to be presented, we measured time-and concentration-dependent changes in intracellular concentrations of ascorbate, the AFR, and DHA to determine relative rates of recycling. We also compared rates of AFR and DHA reduction directly in cell hemolysates. 
EXPERIMENTAL PROCEDURES
Materials-Analytical reagents, including ascorbic acid, ascorbate oxidase (from Curcubita species), aurothioglucose, thioredoxin, diethylmaleate, 2,2,6,6-tetramethyl-4-hydroxy-piperidine-N-oxyl (Tempol), and tetrapentylammonium bromide were supplied by Sigma/Aldrich (St.
Louis, MO). Diethylmaleate was initially dissolved in dimethyl sulfoxide, such that the highest concentration of the latter was 0.8% (v/v) in cells incubated with 2 mM diethylmaleate.
Erythrocyte and erythrocyte hemolysate preparation-Human erythrocytes were obtained from freshly drawn heparinized blood of normal volunteers. The cells were washed three times in ten volumes of phosphate-buffered saline (PBS), which consisted of deionized water containing 140 mM NaCl and 12.5 mM Na 2 PO 4 , pH 7.4. The buffy coat of white cells was removed with each wash. Hemolysates were prepared from washed erythrocytes by diluting packed cells in 100 volumes of deionized water and kept on ice until use.
Assay of ascorbate, DHA, GSH, and reduced pyridine nucleotides-For assay of ascorbate and
GSH, cells were washed 3 times in PBS and packed cells were hemolyzed in 20 volumes of icecold deionized water. For assay of total ascorbate and DHA in a cell aliquot, this water also contained 2 mM dimercaptopropanol. Hemolysates were ultrafiltered by centrifugation at 3 °C for 20 min at 5000 g in a Centricon-10 filter apparatus (Amicon, Inc., Beverly, MA), and aliquots of the clear filtrate was taken for assay of ascorbate and GSH. Ascorbate was assayed by high performance liquid chromatography using electrochemical detection as previously described (32) , except that 1 mM tetrapentylammonium bromide was used as the ion pair 6 reagent. DHA concentrations were calculated by subtracting concentrations of ascorbate from those of total ascorbate and DHA determined in paired aliquots of the same original sample.
There was no interference in the ascorbate assay by the concentration of dimercaptopropanol used to convert DHA to ascorbate in the samples. Conversion of 0.2 mM DHA to ascorbate was complete under these conditions. GSH was measured by the fluorometric method of Hissin and Hilf (33) . Reduced pyridine nucleotides were measured by the method of Zerez, et al. (34) , with minor modifications as previously described (35) . Except where noted, all concentrations were normalized to the intracellular water space of erythrocytes, which was taken as 70% of the packed cell volume (27) .
Measurement of ascorbate-dependent ferricyanide reduction-After incubation of erythrocytes
with ferricyanide as noted, cells were pelleted in a microfuge and aliquots of the supernatant were removed for measurement of ferrocyanide by the method of Avron and Shavit (36), using 2,5-o-phenanthroline as the chelating agent. A cell blank derived from a sample incubated with cells but no ferricyanide was subtracted from each sample.
Measurement of the AFR-Steady-state concentrations of the AFR generated by various concentrations of ascorbate oxidase in the presence of 1 mM ascorbate were measured in pH 7.0 PBS at 360 nm, using an extinction coefficient of 3.3 mM -1 cm -1 to calculate the AFR concentration (37).
Time-dependent changes in the AFR concentration in erythrocyte suspensions were measured by electron paramagnetic resonance (EPR) spectroscopy. EPR data were acquired on a Bruker 7 EMX 8/27 spectrometer equipped with a BVT300 variable temperature controller. Sample temperature was maintained at 37 °C during data acquisition by blowing precooled nitrogen into the cavity through the front optical port. X-band EPR spectra were collected using a ER041XG-DHA microwave bridge and ER4103TM/9614 cavity. Sample incubations were carried out in a Wilmad WG 804 aqueous flow flat cell. Based on a preliminary incubation, the magnetic field was fixed at the value that corresponded to the maximum signal intensity of the low field resonance line of the AFR (arrow, inset spectrum in Figure 3A ). The conversion time of the spectrometer was chosen to result in a sweep time of 167 seconds (since each data set contained 2048 points, the timing resolution was approximately 0.082 seconds/point). Other spectrometer settings were: 0.5 G modulation amplitude, 100 kHz modulation frequency, and 10 mW microwave power. The flat cell was pre-loaded with either buffer or a 40% packed cell volume of erythrocytes to permit tuning of the spectrometer. The experiment was initiated by starting the time-sweep to record a baseline signal. After about 10 seconds, 5 mM ferricyanide was added to the remainder of the pre-warmed sample, which was rapidly injected into the flat cell.
Approximately 15 seconds elapsed between addition of ferricyanide and the start of data recording on the mixed sample. The concentration of the AFR was determined by calibration of the instrument using the signal of 10 µM Tempol. Fig. 2A) . In the absence of glucose, the ascorbate concentration decreased rapidly and had already fallen substantially at the first time point that could be obtained after removal of ferricyanide, which was about 2 min after exposure to ferricyanide. After 22 min of incubation, intracellular ascorbate reached concentrations that were about 10% of those present at the start of incubation, which were 0.16-0.18 mM. Thus, the ability of erythrocytes to maintain intracellular ascorbate is highly dependent on the availability of glucose. Ferricyanide treatment did not cause significant changes in cellular GSH content, whether or not glucose was present ( This suggests very rapid recycling of intracellular ascorbate, and that AFR or DHA concentrations must have markedly increased during ferricyanide reduction. These were measured as described in the next two sections, and both showed substantial increases. shows that although both tended to saturate, the DHA concentrations observed were from 3-7-fold greater than those of the AFR at the same loading DHA concentrations.
Measurement of NADH-dependent AFR and ferricyanide reductase activities-AFR

Ferricyanide-dependent generation of the AFR in erythrocytes-
Using ascorbate-dependent ferricyanide reduction as an estimate of ascorbate recycling, cells loaded by incubation with 0.5 mM DHA that initially contained 0.64 mM ascorbate (0.45 µmol/ml packed cells, Fig. 1A ) were able to reduce 1.8 µmol of ferricyanide/ml packed cells above basal rates in 5 min (Fig. 4A) . Given that one mole of ascorbate reduces 2 moles of ferricyanide, and that the intracellular ascorbate content decreased to 0.13 µmol per ml packed cells during the incubation (Fig. 4A) , these results show that the cells recycled the initial content of ascorbate 1.3 times in 5 min.
Since GSH is a major factor in recycling DHA to ascorbate in erythrocytes (31), intracellular GSH concentrations were also measured in the experiments of Fig. 4 . In cells loaded with increasing amounts of ascorbate as DHA in the presence of glucose, intracellular GSH was unaffected by ferricyanide treatment (Fig. 4C ). However, even though glucose was present during initial DHA loading, subsequent treatment with ferricyanide in the absence of glucose decreased GSH, an effect that became significant at 0.2 mM DHA, and reached a 32% decrease at 1 mM DHA. Although cells started with the same ascorbate concentrations, glucose was needed to maintain GSH during recycling of higher intracellular ascorbate concentrations.
Rates of ferricyanide reduction increased in a saturable manner with increasing intracellular ascorbate due to DHA loading (Fig. 4D) . The absence of glucose during ferricyanide treatment significantly decreased rates of ferricyanide reduction across the range of DHA loading concentrations, but rates at individual DHA loading concentrations were not different. Given the marked effect of omitting glucose during ferricyanide treatment on ascorbate and DHA concentrations ( Fig. 4A and 4B ), the differences in ferricyanide reduction were relatively modest. That is, the cells were able to maintain high rates of ferricyanideinduced ascorbate recycling despite substantial ascorbate oxidation. This high recycling capacity was further exemplified when GSH was selectively depleted, as described next. However, ascorbate-stimulated ferricyanide reduction was only moderately inhibited by diethylmaleate treatment, decreasing only 21% at the highest diethylmaleate concentration used (Fig. 5C ). Rates of ferricyanide reduction were sustained in part by oxidative loss of ascorbate.
GSH depletion and ferricyanide-induced ascorbate recycling-To
For example, about 50% of ascorbate-dependent ferricyanide reduction in cells treated with 2 mM diethylmaleate could be accounted for by ascorbate oxidation alone (Fig. 5A) . The remainder could reflect efficient recycling of ascorbate by GSH-independent mechanisms. To test this possibility, we carried out 5 experiments under the conditions of Fig. 5 , in which 40% packed cells that had been loaded with ascorbate by treatment with 0.5 mM DHA were also treated with 4 µM methylene blue during exposure to diethylmaleate. The inhibition of ascorbate-dependent ferricyanide reduction due to 1 or 2 mM diethylmaleate was decreased by methylene blue an additional 18 ± 4 and 29 ± 5%, respectively. Both decreases are significant compared to controls without methylene blue (P < 0.05). In three experiments, 4 µM methylene blue depleted NADH by 50 ± 4% and NADPH by 48 ± 6% (both P < 0.05 compared to controls).
Neither diethylmaleate nor ferricyanide alone had any effect on NAD(P)H. Thus, oxidation of reduced pyridine nucleotides when ascorbate and GSH were depleted caused a further decrease in ferricyanide reduction. This suggests contribution from ascorbate recycling mechanisms beyond those related to GSH.
Comparison of rates of AFR and DHA regeneration in cell hemolysates-In addition to
measuring changes in AFR and DHA concentrations in response to an oxidant stress, it is also useful to compare rates of AFR reduction relative to those of DHA. However, this approach is not feasible in intact cells, so we studied cell hemolysates, in which the concentrations of various components can be controlled. The AFR was generated using ascorbate oxidase and 1 mM ascorbate, and enzyme-dependent AFR reduction was followed spectrophotometrically as timedependent loss of NADH or NADPH in dilute hemolysates. As shown in Fig. 6A , oxidation of NADPH was increased in a saturable manner by increasing amounts AFR generated by ascorbate oxidase. The data were fit to an hyperbolic function that showed a half-maximal effect at 4.5 ± 0.2 µM AFR, and a maximal rate of 0.76 ± 0.02 nmol A ml -1 A min -1 . Although ascorbate oxidase will not directly generate DHA from ascorbate, DHA is produced from dismutation of two molecules of the AFR. To ensure that enzyme-dependent DHA reduction did not contribute to changes in NADPH concentrations, 1 mM dithiothreitol was included in these incubations.
Dithiothreitol will immediately reduce DHA to ascorbate, preventing NADPH-dependent DHA reduction. However, in subsequent studies it was found that rates of NADPH reduction were unaffected by the presence of dithiothreitol, so it was omitted from the experiments shown in Fig. 6B . In the latter experiments, the rate of NADH oxidation was similar to that of NADPH.
To test the role of thioredoxin reductase in AFR reduction, 5 µM thioredoxin was added to the hemolysate containing NADPH. This doubled the rate of NADPH loss. Further, incubation with 10 µM aurothioglucose inhibited the thioredoxin-stimulated rate of NADPH loss by about 70%.
At this concentration, aurothioglucose is a specific inhibitor of thioredoxin reductase (39) . These results show that erythrocyte hemolysates support NADH-and NADPH-dependent AFR reduction, and that at least part of the latter is due to thioredoxin reductase.
Rates of GSH-dependent DHA reduction in these erythrocyte hemolysates, whether direct or enzyme-dependent, were measured in an assay in which oxidation of GSH was coupled to consumption of NADPH through glutathione reductase. This assay allowed direct comparison of rates of ascorbate recycling from the AFR and from DHA. The dependence of DHA reduction on the DHA concentration was measured and is shown in Fig. 7 , using same amount of hemolysate as that used to measure AFR reduction in Fig. 6 . Rates of NADPH loss increased in a saturable manner reaching levels about 6-fold those of AFR reduction. It should be noted that these rates were corrected for direct reduction of DHA by GSH. The latter also increased with increasing concentrations of DHA, but remained constant as a fraction of enzyme-dependent DHA reduction at 36 ±1.3%. The data were fit to an hyperbolic function that showed a halfmaximal effect at 114 ± 19 µM DHA, and a maximal rate of 4.3 ± 0.3 nmol A ml -1 A min -1 .
Combined rates of direct and enzyme-dependent DHA reduction were over 8-fold greater than rates of AFR reduction.
DISCUSSION
Erythrocytes efficiently recycle ascorbate in the presence of glucose in response to a trans-membrane oxidant stress due to ferricyanide. As diagramed in Fig. 8 , the rate of recycling in this model of trans-membrane oxidant stress depends on the ability of extracellular ferricyanide to oxidize intracellular ascorbate, and on the ability of the cells to recycle ascorbate from the AFR and DHA. Intracellular oxidant stress induced by extracellular ferricyanide has been attributed to a trans-plasma membrane oxidoreductase first described in intact erythrocytes by Orringer and Roer (27) that we subsequently showed to use ascorbate as its preferred intracellular reducing substrate (40) . This oxidoreductase is saturated by concentrations of ferricyanide above 1 mM, regardless of the internal ascorbate concentration (Fig. 1B) . By using 5 mM ferricyanide in these experiments, we could thus be sure that a maximal oxidant stress due to ferricyanide was generated across the oxidoreductase, and that this stress was consistent over the short period of the measurement. Under these conditions, changes in ferricyanide reduction will reflect changes in rates of ascorbate recycling, and not intrinsic changes in activity of the trans-membrane oxidoreductase.
Ferricyanide reduction also saturates with increasing intracellular concentrations of ascorbate (Fig. 4D ). In the presence of glucose, ascorbate-stimulated rates of ferricyanide reduction are half-maximal at an initial DHA loading concentration of 0.1 mM (Fig. 4D) , which corresponds to an initial intracellular ascorbate concentration of about 0.18 mM (Fig. 1A) . After 5 min of ferricyanide treatment, the intracellular ascorbate concentration decreases to about 50 µM (Fig. 4A) . Because of the decreasing intracellular ascorbate concentration, kinetic analysis of these data is not possible. However, it is possible to infer from these results that the mechanisms of ascorbate recycling are saturable, and that recycling is not saturated at concentrations of ascorbate in the physiologic range for plasma and erythrocytes (50-100 µM) (41) . In contrast to other cell types studied thus far, erythrocyte ascorbate concentrations are similar to those in plasma (41, 42) . Therefore, erythrocyte ascorbate recycling is well suited to respond to oxidant stress in the vascular bed with near linear increases in erythrocyte capacity to regenerate ascorbate.
Since ferricyanide is a one-electron oxidant, the AFR will necessarily be generated initially in the cell (Fig. 8) . However, both AFR and DHA are evident during ferricyanide treatment. The appearance of DHA could be due to further oxidation of the AFR by the transmembrane oxidoreductase, or to dismutation of the AFR. Available evidence favors the notion that dismutation is the major route of AFR decomposition. Although the second order rate constant for the dismutation reaction (~2 x 10 6 M -1 s -1 , pH 7.4 (43)) is similar to that for direct reaction of the AFR with ferricyanide (~2 x 10 6 M -1 s -1 , pH 6.0 (44)), the AFR reacts poorly with oxidized forms of cytochromes and ferric heme proteins that might participate in transmembrane electron transfer to extracellular ferricyanide (44) (45) (46) . Further, we found that the AFR, when generated by ascorbate oxidase to steady-state concentrations, was not affected by erythrocyte ghost membranes (47) . Thus, the most likely fate of the AFR generated in erythrocytes will either be to recycle to ascorbate or to dismutate (Fig. 8) .
The AFR is undetectable in erythrocytes incubated in oxygenated buffer, even during loading of ascorbate into the cells by incubation with DHA (31). The latter shows that the AFR is not an intermediate in DHA reduction. In response to a maximal trans-membrane oxidant stress from ferricyanide, the AFR concentration rapidly increases, and, at least at the start of the incubation, is a saturable function of the intracellular ascorbate concentration (Fig. 3B ). Since the AFR carries a negative charge at physiologic pH (48), AFR generated from intracellular ascorbate will remain inside the cells over short times of incubation. Thus the initial AFR concentrations generated by ferricyanide likely reflect function of the endofacial portion of the trans-membrane oxidoreductase. This activity increases linearly over the physiologic range of erythrocyte ascorbate concentrations (up to 150 µM), and can generate intracellular AFR concentrations as high as 22 µM. A biologic function for the trans-membrane oxidoreductase has not been defined, but its intracellular "kinetics" and substrate preference (40) suggest that ascorbate is its electron donor.
AFR concentrations generated by ferricyanide are sustained only at low (i.e., physiologic) intracellular ascorbate concentrations (Fig. 3A) . Cells loaded with ascorbate are unable to maintain the initial maximal AFR concentration under ferricyanide stimulation, although they do this better when glucose is present. As long as the trans-membrane oxidoreductase is not saturated, the AFR concentration follows that of ascorbate. As shown in Fig. 8 , the decrease in the AFR reflects a balance between AFR dismutation and reduction back to ascorbate. Glucose shifts this balance by providing reduced pyridine nucleotides for AFR reduction, and GSH for DHA reduction to ascorbate. Our results provide some insight into the relative contributions of each of these recycling mechanisms in intact cells, as discussed next.
The finding that DHA concentrations were higher than those of the AFR in ascorbateloaded cells stressed with ferricyanide suggests that reduction of both the AFR and DHA were overwhelmed. Moreover, we found that the amount of DHA generated was about 25% greater than measured, which is likely due to its rapid degradation to 2,3-diketogulonic acid and L-erythroascorbic acid. Although we have shown a strong dependence of ascorbate recycling on GSH in erythrocytes (31), the present results indicate that even in the face of severe GSH depletion with diethylmaleate, erythrocytes were able to maintain ascorbate-dependent ferricyanide reduction quite well (Fig. 5) . Decreases in intracellular ascorbate concentrations paralleled decreases in intracellular GSH, attesting to the importance of GSH in ascorbate recycling. However, even with loss of more than 95% of intracellular ascorbate, ascorbatedependent ferricyanide reduction decreased only about 21% (Fig. 5C ). About half of this ability to sustain ascorbate-dependent ferricyanide reduction was due to ascorbate oxidation without recycling, but another 18-29% was lost when NADH and NADPH were depleted by methylene blue. The latter strongly suggests that high affinity ascorbate recycling, such as that due to AFR reduction, accounted for the effect. Together, these results support a role for AFR reduction in erythrocyte ascorbate recycling, especially in cells under strong oxidant stress that contain low ascorbate and GSH concentrations.
Results from erythrocyte hemolysates strengthened the notion of high affinity, low capacity AFR reduction, coupled with a low affinity, high capacity DHA reduction. Erythrocyte hemolysates reduced the AFR at similar rates, using either NADH or NADPH as electron donors. With NADPH in this study (Fig. 6A) , and with NADH in our previous study (47) , AFR reduction was half-maximal at an AFR concentration of 4.5 µM. Whereas NADH-dependent AFR reduction likely reflects the activity of AFR reductase(s) present in the cell membrane (47, 49) , NADPH-dependent activity appears to be due, at least in part, to thioredoxin reductase in the cytosol (Fig. 8) . We reported previously that rat liver thioredoxin reductase can reduce the AFR to ascorbate (15), and the present results show that the human erythrocyte enzyme has a similar function. Nonetheless, the total NAD(P)H-dependent AFR reductase activity of hemolysates was only a fraction of that observed for enzyme-dependent DHA reduction in the NADPHcoupled assay. Such GSH-dependent DHA reduction has been shown for several enzymes, including protein disulfide isomerase (50) , glutaredoxin (50, 51) , and an M r = 31-32,000 protein in rat liver (52) and human erythrocytes (53) . Thus, in erythrocytes under little oxidant stress, the AFR will be generated in amounts that can be handled by the high affinity AFR reductases, and DHA will not accumulate substantially. However, in cells under more severe oxidant stress, such as those in the present study, both GSH-and NADPH-dependent DHA reduction provides a back-up mechanism to prevent loss of ascorbate (Fig. 8 ). This concept of a two-tiered system fits well with the findings of Coassin, et al. (20) in homogenates of various pig organs. These authors also concluded that AFR reduction is the primary route of ascorbate recycling when DHA concentrations are expected to be low.
In conclusion, human erythrocytes subjected to a trans-membrane oxidant stress from ferricyanide rapidly recycle intracellular ascorbate through mechanisms dependent on reduction of both the AFR and DHA. AFR reduction, which occurs by both NADH-and NADPHdependent reductases, predominates when oxidant stress is not severe, as well as when both ascorbate and GSH is severely depleted. On the other hand, when DHA is generated in cells that have adequate GSH reserves, GSH-dependent reduction of DHA is favored. The presence of two separate mechanisms for ascorbate recycling with differing affinities and capacities provides redundancy that ensures preservation of intracellular ascorbate. 
